

Buy anything from 5,000+ international stores. One checkout price. No surprise fees. Join 2M+ shoppers on Desertcart.
Desertcart purchases this item on your behalf and handles shipping, customs, and support to Argentina.
🧬 Unlock the biotech revolution’s origin story before everyone else does!
‘Genentech: The Beginnings of Biotech’ chronicles the groundbreaking rise of Genentech, the pioneering genetic engineering company that transformed biotechnology and Wall Street alike. Drawing on exclusive interviews and detailed research, this book reveals how visionary entrepreneurship and cutting-edge science converged to create a biotech empire, making it an essential read for professionals eager to understand the roots of today’s biotech industry.
| Best Sellers Rank | #136,364 in Books ( See Top 100 in Books ) #44 in Biotechnology #1,523 in Industries #2,166 in Engineering |
| Customer Reviews | 4.7 out of 5 stars 96 Reviews |
M**O
A fantastic account of the beginnings of biotechnology
It may be fair to say that outsiders - and insiders alike - have always been impressed and fascinated by the output and achievements of Genentech. Sally Hughes' account is full of excellent insights on its genesis, involving a persistent, uncommonly driven and enthusiastic entrepreneur and a perhaps bemused, established research scientist who should have probably won a Noble Prize. Full of entertaining and at times bewildering stories on its progress, it will certainly help people less familiar with research settings get an insider's view on how this field progresses - and what genuine drive focused on outstanding science can lead to. For those familiar with biotechnology and other research areas, it may well be a must.
B**N
バイオベンチャー創成期の貴重な記録
1970年代、経済不調に苦しんでいた米国で、最新の科学技術を産業化する企業形態である「ベンチャー(企業)」が誕生した。アップルなどのITベンチャーの創業物語に関する書籍は多数存在するが、双璧のもう一方であるバイオベンチャーの創業については、広く語られることは少なかったように思われる。本書は、奇しくもアップル創業の6日後の1976年4月7日に設立され、武田薬品をも上回る製薬企業に成長したジェネンテク社の創業の経緯を、多数の客観的資料に基いて著者が第三者の視点でまとめたものである。 本書においては、遺伝子組み換え技術によって生産されたインスリンなどの医薬品化を通じてジェネンテク社が企業として成長し、上場を達成するまでの経緯が、日本人科学者・板倉啓壱博士を含む当事者へのインタビューなどの膨大な資料に基いて記録され、アカデミック独特の思考方法の克服・バイオベンチャーキャピタルからの出資・マイルストンの設定と出口戦略などなど、バイオベンチャーにおいて重要な課題をひとつひとつ乗り越えていく姿が描かれる。記述はあくまで客観的であるが、わずか4年半で創業から上場までを駆け抜けた当事者の葛藤も行間から汲み取ることができる。これらの点で、本書は「バイオベンチャー」を語るときに欠かせない資料となるべき好著である。
Y**N
Excellent book
M**N
Great read for a biologist
Highly recommend. The book is mostly technical, and doesn't go into the personal lives of any of the founders or original employees, and sometimes I feel myself craving more detail - it's a short read. Overall, however, a fun story and interesting for me, in particular, because I'm studying a related field 40 years later, and it's great to see how molecular cloning techniques got their start in industry.
R**D
Well worth the reader's time and effort.
The title pretty well explains the subject of Genentech. Hughes does not spare scientific detail, but she writes about it deftly, blending the science into the narrative. Readers with even the most basic understanding of genetics will hardly notice that they have gotten a short lesson on recombinant technology along with a great story.
Trustpilot
1 month ago
5 days ago